Feldan Bio inc.
$600,000.00 CAD
≈ 8 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2017-2018
- Agreement period
- January 18, 2018 – March 31, 2021
- Reference
- nrc-cnrc:GC-2017-Q3-32861
Published purpose
Natural killer (NK) cells play a crucial role in the control of tumors, making them appealing for immunotherapy. Alongside Green Cross LabCell, Feldan aims to genetically modify NK cells to improve their potential for allogeneic engraftment and their cytotoxicity against tumors. This project will lead to the development of universal, off-the-shelf and hyperactive NK cells for immuno-oncology therapies.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions